SelectQuote, Inc. Common Stock (SLQT)

SelectQuote (SLQT) Q1 2026 Earnings Transcript

SelectQuote (SLQT) reported mixed Q1 FY2026 results, beating revenue estimates but posting a net loss. The stock fell sharply as investors focused on challenges in its Senior segment.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

SelectQuote has a very low P/E and just beat on earnings. Is it safe to buy?

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Shares of SelectQuote are trading sharply higher Thursday afternoon. The company announced Q4 revenue of $345.1 million, beating the consensus estimate.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

SelectQuote (SLQT) reported Q4 revenue of $345.1M, beating estimates. EPS improved to -$0.17. Strong Healthcare Services growth drove a return to net income.

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Shares of eHealth, GoHealth and SelectQuote plummeted on Thursday. A sweeping federal complaint alleges the companies took part in a multi-year Medicare fraud scheme.

Let's have a look at the gap up and gap down stocks in today's session.

SLQT earnings call for the period ending December 31, 2024.

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

SelectQuote stock is trading higher on Tuesday after the company reported better-than-expected 2025 fiscal-year second-quarter earnings on Monday after the market closed.